The effects of resistance training and Nigella sativa on type 2 diabetes

The effects of resistance training and Nigella sativa on type 2 diabetes: implications for metabolic markers, low-grade inflammation and liver enzyme production

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190103042219N3

Enrollment

Registered

2020-07-14

Start date

2019-11-26

Completion date

Unknown

Last updated

2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes. Diabetes mellitus due to underlying condition

Interventions

Intervention 1: Control group: There are 10 subjects in this group and they receive placebo intervention. Subjects received capsules that contained (500 ± 10 mg) of maltodextrin as a placebo. Capsule

Eligibility

Sex/Gender

Female

Age

35 Years to 50 Years

Inclusion criteria

Inclusion criteria: Middle-aged women (35-50 yr old) Type 2 diabetes In the health center of Borazjan in Iran

Exclusion criteria

Exclusion criteria: Previous or current insulin therapy History of cardiovascular disease Use of antioxidant, anti-inflammation, and corticosteroid medicines

Design outcomes

Primary

Measure	Time frame
Insulin. Timepoint: 48 hours before the start and 72 hours after the completion of the protocol. Method of measurement: ELISA kit.;Glucose. Timepoint: 48 hours before the start and 72 hours after the completion of the protocol. Method of measurement: ELISA kit.;Total cholesterol. Timepoint: 48 hours before the start and 72 hours after the completion of the protocol. Method of measurement: ELISA kit.;High density lipoprotein. Timepoint: 48 hours before the start and 72 hours after the completion of the protocol. Method of measurement: ELISA kit.;Low density lipoprotein. Timepoint: 48 hours before the start and 72 hours after the completion of the protocol. Method of measurement: ELISA kit.;Triglyceride. Timepoint: 48 hours before the start and 72 hours after the completion of the protocol. Method of measurement: ELISA kit.	—

Measure

Time frame

Insulin. Timepoint: 48 hours before the start and 72 hours after the completion of the protocol. Method of measurement: ELISA kit.;Glucose. Timepoint: 48 hours before the start and 72 hours after the completion of the protocol. Method of measurement: ELISA kit.;Total cholesterol. Timepoint: 48 hours before the start and 72 hours after the completion of the protocol. Method of measurement: ELISA kit.;High density lipoprotein. Timepoint: 48 hours before the start and 72 hours after the completion of the protocol. Method of measurement: ELISA kit.;Low density lipoprotein. Timepoint: 48 hours before the start and 72 hours after the completion of the protocol. Method of measurement: ELISA kit.;Triglyceride. Timepoint: 48 hours before the start and 72 hours after the completion of the protocol. Method of measurement: ELISA kit.

—

Secondary

Measure	Time frame
Body weight. Timepoint: 48 hours before the start and 72 hours after the completion of the protocol. Method of measurement: Digital Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Ali Azarbayjani Ph.D

Islamic Azad University, Central Tehran Branch

m_azarbayjani@iauctb.ac.ir+98 21 2248 1622

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026